Insulet

Insulet Cost of Goods Sold

The Cost of Goods Sold (COGS) of Insulet (PODD) as of Nov 20, 2026 is 768.20 M USD. In the previous year, Cost of Goods Sold (COGS) was 625.90 M USD — a change of 22.74% (higher).

Cost of Goods Sold

768.20 MUSD

YoY

22.74%

Last updated:

Cost of Goods Sold (COGS) of Insulet is 2025 768.20 M USD. Cost of Goods Sold (COGS) of Insulet was 2024 625.90 M USD. It decreases by 22.74% higher compared to the previous year.

The Insulet Cost of Goods Sold history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cost of Goods Sold
Date
Cost of Goods Sold
Jan 1, 2018
193.66 M USD
Jan 1, 2019
257.90 M USD
Jan 1, 2020
322.10 M USD
Jan 1, 2021
346.70 M USD
Jan 1, 2022
499.70 M USD
Jan 1, 2023
537.20 M USD
Jan 1, 2024
625.90 M USD
Jan 1, 2025
768.20 M USD
The Insulet Cost of Goods Sold history
YEARCost of Goods SoldYoY
768.20 MUSD+22.74%
625.90 MUSD+16.51%
537.20 MUSD+7.50%
499.70 MUSD+44.13%
346.70 MUSD+7.64%
322.10 MUSD+24.89%
257.90 MUSD+33.17%
193.66 MUSD+3.78%
186.60 MUSD+19.69%
155.90 MUSD+19.35%
130.62 MUSD-10.18%
145.43 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Insulet Stock analysis

What does Insulet do? Insulet Corp is an American company that was founded in 2000 and is headquartered in Acton, Massachusetts. Its goal is to improve the quality of life for people with diabetes by developing innovative products that make living with this chronic disease easier. Insulet Corp is known for its product "OmniPod." The OmniPod is a wireless, portable disposable insulin pump system that offers an alternative option to traditional pumping and insulin delivery systems. The OmniPod system consists of two small devices: a pod worn on the skin and a PDM (Personal Diabetes Manager) that regulates insulin delivery. The pod contains an insulin reservoir that communicates wirelessly with the PDM. The insulin dose is administered directly into the body without needles or tubes. Insulet Corp is also introducing the "OmniPod DASH System." This new system combines the proven design of the OmniPod pod with a new color touchscreen handheld device that allows for even easier operation. The DASH system also offers the ability to control insulin dosing from a smartphone, which can be taken with diabetics wherever they go. The success of the OmniPod system has made Insulet Corp a leading company in the diabetes industry. The company has also developed and introduced products and services in other areas of diabetes treatment. Insulet Corp has developed another product called "Amigo." This product is a personalized travel and training program for people who require insulin. Amigo offers specialized and personalized training to support diabetics in managing complex situations. It also offers diet and exercise plans to make living with diabetes easier. Insulet Corp has also developed a software called "OmniPod Horizon." This software is a closed-loop system that automatically adjusts insulin dosing to keep blood sugar levels within the target range. The system is currently in the development phase and is expected to be released in 2020. Insulet Corp has also developed a program called the "OmniPod Partner Program," which targets doctors and pharmacists. The program provides training and educational materials for healthcare providers to help them better treat and manage their patients. Since 2009, Insulet Corp has been listed on the NASDAQ stock exchange and has continuously evolved since then. The company currently has over 1500 employees and operates in North America, Europe, and the Middle East. Insulet Corp is a company focused on the development of innovative, life-changing products and services. It is expected to continue to play a significant role in improving the quality of life for people with diabetes in the future. Insulet is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Insulet stock

Cost of Goods Sold (COGS) of Insulet is 768.20 M USD in 2025.

Cost of Goods Sold (COGS) of Insulet changed from 625.90 M USD to 768.20 M USD, representing a 22.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cost of Goods Sold (COGS) Insulet since 2006 – with annual values, charts, and detailed analysis.

COGS represents the direct costs attributable to the production of goods sold. It includes material and labor costs directly tied to the product.

Cost of Goods Sold (COGS)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Cost of Goods Sold (COGS)'s Insulet historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Insulet

All Key Metrics — Insulet